A Single-Dose, Open-Label, Two-Part, Randomized, Crossover Formulation Bridging and Food Effect Study to Assess the Effect of Formulation and Food on the Absorption and Bioavailability of PBI-200 in Normal Healthy Volunteers
Latest Information Update: 06 Feb 2023
At a glance
- Drugs PBI-200 (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Pyramid Biosciences
Most Recent Events
- 25 Jan 2023 New trial record